Core C - HDL Quantitation
$557,006P01FY2016HLNIH
Vanderbilt University Medical Center, Nashville TN
Investigators
Linked publications & trials
Paper 39490930Paper 39450930Paper 39162237Paper 38828596Paper 38660807Paper 38490635Paper 38320926Paper 38246236Paper 38160756Paper 37986833Paper 37961344Paper 37647397Paper 37548415Paper 37100172Paper 36895046Paper 36737730Paper 35974019Paper 35120130Paper 35051413Paper 34800735Paper 34634315Paper 33772657Paper 32819213Paper 32762496Paper 32198194Paper 31869273Paper 31597668Paper 31597448Paper 31382838Paper 31092010Paper 31049150Paper 30701961Paper 30659061Paper 30244943Paper 29773713Paper 29712830Paper 29367232Paper 29131142Paper 29113513Paper 28683965Paper 28476857Paper 27428858
Abstract
A key goal of biomedical investigators interested in HDL is to establish the relationships between the structure and function of the lipoprotein. The HDL Quantitation Core will provide the powerful tools of mass spectrometry and quantification of HDL particle size and concentration to PPG investigators. Core personnel have documented expertise in these areas, and their capabilities will support PPG investigators with a standardized, validated set of common assays. Core C will also optimize efficiency and cost-effectiveness by providing these services in a central laboratory.
View original record on NIH RePORTER →